6WXN

EGFR(T790M/V948R) in complex with LN3844

Summary for 6WXN

• Entry DOI: 10.2210/pdb6wxn/pdb
• Descriptor: Epidermal growth factor receptor, N-(3-{5-[2-(acetylamino)pyridin-4-yl]-2-(methylsulfanyl)-1H-imidazol-4-yl}phenyl)-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-6-fluoro-3-hydroxybenzamide, PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER, ... (6 entities in total)
• Functional Keywords: cancer, inhibitor, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 4
• Total formula weight: 151756.73

Authors

Heppner, D.E.,Eck, M.J. (deposition date: 2020-05-11, release date: 2021-05-19, Last modification date: 2023-10-18)

• Primary citation: Wittlinger, F.,Heppner, D.E.,To, C.,Gunther, M.,Shin, B.H.,Rana, J.K.,Schmoker, A.M.,Beyett, T.S.,Berger, L.M.,Berger, B.T.,Bauer, N.,Vasta, J.D.,Corona, C.R.,Robers, M.B.,Knapp, S.,Janne, P.A.,Eck, M.J.,Laufer, S.A.; Design of a "Two-in-One" Mutant-Selective Epidermal Growth Factor Receptor Inhibitor That Spans the Orthosteric and Allosteric Sites.; J.Med.Chem., 65:1370-1383, 2022; PubMed: 34668706; DOI: 10.1021/acs.jmedchem.1c00848

Experimental method

X-RAY DIFFRACTION (1.76 Å)